Headline News

[Sue Gould]

Investment Times Alert: STRONG

We Told you at .31 and now its .40 and we think 
it goes to $1 on expected news this week. 

Harbin Pingchuan Pharmaceutical: PGCN
Current Price: $0.40 
Shares Outstanding: 20 Million 
Market Capitalization: $6 Million 
Short Term Target: $1.75 
12month Target: $10.00 

We told you there was going to be a BIG move and we where right! 

PGCN MAKES HUGH MOVE, We can't wait until Wednesday!!! 

*********INVESTER ALERT ISSUED FOR Wednesday********* 

HARBIN, China, /Xinhua-PRNewswire-FirstCall/ -- Harbin Pingchuan 
Pharmaceutical Holding Co. Ltd. (OTC Bulletin Board: PGCN - News; 
"PINGCHUAN") announced today that PINGCHUAN signed a Purchase Agreement 
with the Guangdong Medicine Group Co. Ltd. ("GDMG"). 
Under the terms of the agreement, PINGCHUAN will authorize GDMG as its 
franchisee in five southern provinces of China. With respect to the 
authorization, GDMG intends to purchase approximately US$2.00million worth 
of PINGCHUAN's pharmaceutical products in 2005. By cooperating with GDMG, 
PINGCHUAN will greatly enhance the marketing network and sales channels in 
Southern China. 

Reason:
Make no mistake: Our mission at SmallCap-Investors is to claw our way 
through the thousands of underperforming companies out there to find 
the golden needle in the haystack the micro-cap DIAMOND 
that can make you rich. More often than not, the stocks we profile 
show a significant increase in stock price and sometimes in days, 
not months or years. We have come across what we feel is one of those 
rear deals that the public has not heard about yet.
***GOOD LUCK***